Health
Pharmaceutical Advertising Faces Political Pressure
Bipartisan legislation is being introduced to ban or restrict direct-to-consumer pharmaceutical advertising, while states are considering similar measures. The practice is under increasing scrutiny for its costs and potential harm.
Coverage timeline — 1 article
The Hill
Direct-to-consumer pharmaceutical advertising is under increasing political pressure, with bipartisan legislation being introduced to ban or restrict the practice, and states considering bills to deny tax deductions for pharmaceutical advertising expenses.
2026-06-08 17:30 UTC